Literature DB >> 8264699

Dystrophin-glycoprotein complex: its role in the molecular pathogenesis of muscular dystrophies.

K Matsumura1, K P Campbell.   

Abstract

Dystrophin, the protein product of the Duchenne muscular dystrophy (DMD) gene, is associated with a large oligomeric complex of sarcolemmal glycoproteins, including dystroglycan which provides a linkage to the extracellular matrix component, laminin. In patients with DMD, the absence of dystrophin leads to the loss in all of the dystrophin-associated proteins, causing the disruption of the linkage between the subsarcolemmal cytoskeleton and the extracellular matrix. This may render the sarcolemma vulnerable to physical stress. These recent developments in the research concerning the function of the dystrophin-glycoprotein complex pave a way for the better understanding of the pathogenesis of muscular dystrophies.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8264699     DOI: 10.1002/mus.880170103

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  72 in total

Review 1.  Understanding dystrophinopathies: an inventory of the structural and functional consequences of the absence of dystrophin in muscles of the mdx mouse.

Authors:  J M Gillis
Journal:  J Muscle Res Cell Motil       Date:  1999-10       Impact factor: 2.698

2.  Segregation of two spectrin isoforms: polarized membrane-binding sites direct polarized membrane skeleton assembly.

Authors:  R R Dubreuil; P B Maddux; T A Grushko; G R MacVicar
Journal:  Mol Biol Cell       Date:  1997-10       Impact factor: 4.138

3.  The GTPase RhoA increases utrophin expression and stability, as well as its localization at the plasma membrane.

Authors:  Armelle Bonet-Kerrache; Mathieu Fortier; Franck Comunale; Cécile Gauthier-Rouvière
Journal:  Biochem J       Date:  2005-10-15       Impact factor: 3.857

4.  AChR phosphorylation and aggregation induced by an agrin fragment that lacks the binding domain for alpha-dystroglycan.

Authors:  T Meier; M Gesemann; V Cavalli; M A Ruegg; B G Wallace
Journal:  EMBO J       Date:  1996-06-03       Impact factor: 11.598

5.  Activated calcineurin ameliorates contraction-induced injury to skeletal muscles of mdx dystrophic mice.

Authors:  Nicole Stupka; David R Plant; Jonathan D Schertzer; Tennent M Emerson; Rhonda Bassel-Duby; Eric N Olson; Gordon S Lynch
Journal:  J Physiol       Date:  2006-06-22       Impact factor: 5.182

6.  Efficacy of systemic morpholino exon-skipping in Duchenne dystrophy dogs.

Authors:  Toshifumi Yokota; Qi-Long Lu; Terence Partridge; Masanori Kobayashi; Akinori Nakamura; Shińichi Takeda; Eric Hoffman
Journal:  Ann Neurol       Date:  2009-06       Impact factor: 10.422

Review 7.  High-content drug screening with engineered musculoskeletal tissues.

Authors:  Herman Vandenburgh
Journal:  Tissue Eng Part B Rev       Date:  2010-02       Impact factor: 6.389

8.  Similarity of ATP-dependent K+ channels in skeletal muscle fibres from normal and mutant mdx mice.

Authors:  B Allard; O Rougier
Journal:  J Physiol       Date:  1997-01-15       Impact factor: 5.182

9.  Autophagy regulates satellite cell ability to regenerate normal and dystrophic muscles.

Authors:  E Fiacco; F Castagnetti; V Bianconi; L Madaro; M De Bardi; F Nazio; A D'Amico; E Bertini; F Cecconi; P L Puri; L Latella
Journal:  Cell Death Differ       Date:  2016-07-22       Impact factor: 15.828

10.  A duchenne muscular dystrophy gene hot spot mutation in dystrophin-deficient cavalier king charles spaniels is amenable to exon 51 skipping.

Authors:  Gemma L Walmsley; Virginia Arechavala-Gomeza; Marta Fernandez-Fuente; Margaret M Burke; Nicole Nagel; Angela Holder; Rachael Stanley; Kate Chandler; Stanley L Marks; Francesco Muntoni; G Diane Shelton; Richard J Piercy
Journal:  PLoS One       Date:  2010-01-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.